Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Hyperplasia × Everolimus × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 90 Carcinoma, Renal Cell 63 Neoplasm Metastasis 41 Neoplasms 34 Neuroendocrine Tumors 29 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 15 Head and Neck Neoplasms 14 Triple Negative Breast Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma 12 Hodgkin Disease 12 Glioblastoma 12 Colorectal Neoplasms 12 Brain Neoplasms 12 Sarcoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Carcinoma, Hepatocellular 11 Carcinoma, Neuroendocrine 10 Waldenstrom Macroglobulinemia 9 Stomach Neoplasms 9 Multiple Myeloma 9 Lymphoma, Follicular 9 Lung Neoplasms 9

Interventions

Megestrol Acetate 5 Medroxyprogesterone Acetate 3 Tirzepatide 2 Progestins 2 Progesterone 2 Metformin 2 Letrozole 2 Atorvastatin 2 ricin A-GnRH conjugate 1 exemestane 1 estradiol, norethindrone drug combination 1 Tamoxifen 1 Rosuvastatin Calcium 1 Pterocarpus marsupium 1 Pharmacogenomic Variants 1 Levonorgestrel 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Hysterectomy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Gonadotropin-Releasing Hormone 1 Genetic Testing 1 Everolimus 1 Cyproterone acetate, ethinyl estradiol drug combination 1 Curettage 1 Bupivacaine 1 Biopsy 1 3,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02397083 2026-02-13

LEVER

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡